Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 10 2020 - 7:07AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2020
Commission File Number 001-38370
CollPlant Biotechnologies Ltd.
(Exact name of registrant as specified in its
charter)
4 Oppenheimer St, Weizmann Science Park
Rehovot 7670104, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐
The first and second paragraphs and “Forward
Looking Statements” of the press release attached to this Form 6-K are hereby incorporated by reference into the registrant’s
Registration Statements on Form S-8 (File No. 333-229163 and 333-248479) and Form F-3 (File No. 333-229486, 333-228054 and 333-238731),
to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently
filed or furnished.
Attached hereto as Exhibit 99.1 and
incorporated by reference herein is a press release issued by CollPlant Biotechnologies Ltd. entitled “CollPlant Announces
Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients”.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
COLLPLANT BIOTECHNOLOGIES LTD.
|
|
|
|
Date: November 10, 2020
|
By:
|
/s/ Eran Rotem
|
|
|
Name:
|
Eran Rotem
|
|
|
Title:
|
Deputy CEO and Chief Financial Officer
|
CollPlant Biotechnologies (NASDAQ:CLGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
CollPlant Biotechnologies (NASDAQ:CLGN)
Historical Stock Chart
From Apr 2023 to Apr 2024